Plasma Policy Insights: Navigating Challenges and Solutions

Plasma-derived medicinal products (PDMPs) are essential in treating a range of rare and life-threatening diseases, yet the availability and efficacy of these therapies heavily depend on the policies governing plasma collection, processing, and distribution.
As the global healthcare landscape evolves, policymakers, healthcare professionals, and stakeholders encounter unique challenges and opportunities in shaping effective plasma policies. The discussion highlights the diverse approaches adopted by countries with established frameworks and those working to create and implement effective strategies in this area. Through knowledge exchange, sharing of best practices, and identifying avenues for collaboration, this panel aims to support global efforts to refine and enhance plasma policies.
Learn more about this important initiative: www.plasma4.life
---------------------------------------------------------------------------
The United Nations Institute for Training and Research (UNITAR) delivers innovative training and conducts research on knowledge systems to increase the capacity of beneficiaries to respond to global and constantly evolving challenges.
------------------
Stay tuned:
Facebook: / unitarhq
LinkedIn: / unitarhq
Twitter: / unitar
Instagram: www.instagram....
Website: unitar.org/